Skip to content

Trinity Biotech plc on a $45 million strategic investment by MiCo

Following this investment, MiCo will hold 29.9% of the voting share capital of Trinity. In addition to the newly issued equity, Trinity has agreed to issue a seven-year, unsecured junior convertible note in the amount of $20 million to MiCo.

The Matheson team was led by partners David Fitzgibbon and David Jones.

© 2025 Matheson LLP | All Rights Reserved